Transcriptional regulation of T helper 17 cell differentiation

Yonsei Medical Journal

Volumn 51, Issue 4, 2010, Pages 484-491

  Hwang, Eun Sook ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Il 6; Tgf ; Thelper 17; Transcription factor

Indexed keywords

[5 (2,4 DICHLOROBENZOYL) 2 HYDROXYPHENYL]ACETIC ACID; B CELL ACTIVATING TRANSCRIPTION FACTOR; EPIDERMAL FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID RELATED ORPHAN RECEPTOR GAMMA T; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BATF PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ASTHMA; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NONHUMAN; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; TH17 CELL; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; PHYSIOLOGY;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-17; INTERLEUKIN-6; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PPAR GAMMA; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956215618     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.4.484     Document Type: Review

References (92)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition accord- ing to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
2. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933-44.
3. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage com- mitment. Cell 2000;100:655-69.
4. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998;9:745-55.
5. Ho IC, Lo D, Glimcher LH. C-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med 1998; 188:1859-1866.
6. Kiwamoto T, Ishii Y, Morishima Y, Yoh K, Maeda A, Ishizaki K, et al. Transcription factors T-bet and GATA-3 regulate devel- opment of airway remodeling. Am J Respir Crit Med 2006;174: 142-151.
7. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
8. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19:652-7.
9. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
10. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-86.
11. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126:1121-33.
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of patho genic effector TH17 and regulatory T cells. Nature 2006;441: 235-238.
13. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-974.
14. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006;441:231-234.
15. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189.
16. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999;18:1280-1291.
17. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007;26:371-381.
18. Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differen- tiation. J Exp Med 2002;195:1499-505.
19. Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000;165:4773-4777.
20. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007;178:179-185.
21. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2- deficient mice from autoimmunity. J Immunol 2007;178:172-178.
22. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and func- tion of human interleukin 17-producing helper T cells. Nat Im- munol 2007;8:950-957.
23. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-949.
24. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the genera- tion of inflammatory T cells. Nature 2007;448:480-483.
25. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007;282: 9358-9363.
26. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, et al. Stat3 and Stat4 direct development of IL-17- secreting Th cells. J Immunol 2007;178:4901-7.
27. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, et al. Selective regulatory function of Socs3 in the formation of IL17-secreting T cells. Proc Natl Acad Sci U S A 2006;103: 8137-8142.
28. Eberl G, Littman DR. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol Rev 2003;195:81-90.
29. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, et al. Requirement for RORgamma in thymocyte survi- val and lymphoid organ development. Science 2000;288:2369-2373.
30. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008;28:29-39.
31. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 2002;195:1003-1012.
32. Lohoff M, Mittrücker HW, Prechtl S, Bischof S, Sommer F, Kock S, et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A 2002;99:11808-12.
33. Brüstle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007;8:958-966.
34. Huber M, Brüstle A, Reinhard K, Guralnik A, Walter G, Mahiny A, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 2008;105:20846-20851.
35. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009;30:576-587.
36. Littman DR, Sun Z, Unutmaz D, Sunshine MJ, Petrie HT, Zou YR. Role of the nuclear hormone receptor ROR gamma in trans- criptional regulation, thymocyte survival, and lymphoid organogenesis. Cold Spring Harb Symp Quant Biol 1999;64:373-381.
37. Chen Z, Laurence A, O'Shea JJ. Signal transduction pathways and transcriptional regulation in the control of Th17 differen- tiation. Semin Immunol 2007;19:400-408.
38. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos- Jun interactions that mediate transcription regulatory specificity. Oncogene 2001;20:2438-2452.
39. Dorsey MJ, Tae HJ, Sollenberger KG, Mascarenhas NT, Johan-Sen LM, Taparowsky EJ. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 1995;11:2255-2265.
40. Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 2000;19:1752-1763.
41. Williams KL, Nanda I, Lyons GE, Kuo CT, Schmid M, Leiden JM, et al. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur J Immunol 2001; 31:1620-1627.
42. Deppmann CD, Thornton TM, Utama FE, Taparowsky EJ. Phos- phorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulation. Biochem J 2003;374: 423-431.
43. Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, et al. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem 2001;276: 18579-18590.
44. Hasegawa T, Zhou X, Garrett LA, Ruteshouser EC, Maity SN, de Crombrugghe B. Evidence for three major transcription activa- tion elements in the proximal mouse proalpha2(I) collagen promoter. Nucleic Acids Res 1996;24:3253-3260.
45. Meyer NP, Johansen LM, Tae HJ, Budde PP, Williams KL, Tapa- rowsky EJ. Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1. Mamm Genome 1998;9:849-852.
46. Johansen LM, Deppmann CD, Erickson KD, Coffin WF, 3rd, Thornton TM, Humphrey SE, et al. EBNA2 and activated Notch induce expression of BATF. J Virol 2003;77:6029-6040.
47. Senga T, Iwamoto T, Humphrey SE, Yokota T, Taparowsky EJ, Hamaguchi M. Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene 2002;21:8186-8191.
48. Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B, et al. The AP-1 transcription factor Batf controls T(H)17 differen- tiation. Nature 2009;460:405-409.
49. Martinez GJ, Dong C. BATF: bringing (in) another Th17-regulat- ing factor. J Mol Cell Biol 2009;1:66-68.
50. Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G, et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008;38:3274-3281.
51. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. The phenotype of human Th17 cells and their precursors, the cyto- kines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 2008;20:1361-1368.
52. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008;29:44-56.
53. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008;453:236-240.
54. Ichiyama K, Yoshida H, Wakabayashi Y, Chinen T, Saeki K, Na- kaya M, et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgam- mat. J Biol Chem 2008;283:17003-17008.
55. Mathur AN, Chang HC, Zisoulis DG, Kapur R, Belladonna ML, Kansas GS, et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 2006;108: 1595-1601.
56. Fujiwara M, Hirose K, Kagami S, Takatori H, Wakashin H, Tamachi T, et al. T-bet inhibits both TH2 cell-mediated eosino- phil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol 2007;119:662-670.
57. Gocke AR, Cravens PD, Ben LH, Hussain RZ, Northrop SC, Racke MK, et al. T-bet regulates the fate of Th1 and Th17 lympho- cytes in autoimmunity. J Immunol 2007;178:1341-1348.
58. Durrant DM, Gaffen SL, Riesenfeld EP, Irvin CG, Metzger DW. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol 2009;183:5293-300.
59. Rutitzky LI, Smith PM, Stadecker MJ. T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur J Immunol 2009; 39:2470-2481.
60. Abromson-Leeman S, Bronson RT, Dorf ME. Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNgamma but have a spectrum of IL-17 profiles. J Neuroimmunol 2009;215:10-24.
61. Guo S, Cobb D, Smeltz RB. T-bet inhibits the in vivo differen- tiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. J Immunol 2009;182:6179-6186.
62. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, et al. T-bet negatively regulates autoim- mune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006;203:2009-2019.
63. Grenningloh R, Kang BY, Ho IC. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 2005;201:615-626.
64. Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC. Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 2007;204: 2825-2835.
65. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009;10: 1252-1259.
66. Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, et al. Asymmetry in the PPARgamma/RX- Ralpha crystal structure reveals the molecular basis of heterodi- merization among nuclear receptors. Mol Cell 2000;5:545-555.
67. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, et al. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res 1994;22:5628-5634.
68. Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2005;102:6207-6212.
69. Chui PC, Guan HP, Lehrke M, Lazar MA. PPARgamma regul- ates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest 2005;115:2244-2256.
70. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adi- pose tissue in vivo and in vitro. Mol Cell 1999;4:611-617.
71. Na HK, Surh YJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 2003;66:1381-1391.
72. Chen CW, Chang YH, Tsi CJ, Lin WW. Inhibition of IFN-gam- ma-mediated inducible nitric oxide synthase induction by the per- oxisome proliferator-activated receptor gamma agonist, 15-deoxy- delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J Immunol 2003;171: 979-988.
73. Schmidt S, Moric E, Schmidt M, Sastre M, Feinstein DL, Heneka MT. Anti-inflammatory and antiproliferative actions of PPAR- gamma agonists on T lymphocytes derived from MS patients. J Leukoc Biol 2004;75:478-485.
74. Klotz L, Dani I, Edenhofer F, Nolden L, Evert B, Paul B, et al. Peroxisome proliferator-activated receptor gamma control of den- dritic cell function contributes to development of CD4+ T cell anergy. J Immunol 2007;178:2122-2131.
75. Szatmari I, Töröcsik D, Agostini M, Nagy T, Gurnell M, Barta E, et al. PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 2007;110: 3271-3280.
76. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005; 437:759-763.
77. Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007;28:551-558.
78. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Pud- dington L, Padula SJ. The nuclear receptor PPAR gamma and im- munoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 2000;164:1364-1371.
79. Won HY, Min HJ, Ahn JH, Yoo SE, Bae MA, Hong JH, et al. Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation. Biochem Pharmacol 2010;79:888-896.
80. Meyers CD, Kashyap ML. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection. Curr Opin Cardiol 2004;19:366-373.
81. Xu J, Barger SW, Drew PD. The PPAR-gamma Agonist 15- Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Produc- tion of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease. PPAR Res 2008;2008:349185.
82. Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, et al. The nuclear receptor PPAR gamma selectively inhibits Th17 dif- ferentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 2009;206:2079-2089.
83. Li B, Reynolds JM, Stout RD, Bernlohr DA, Suttles J. Regulation of Th17 differentiation by epidermal fatty acid-binding protein. J Immunol 2009;182:7625-33.
84. Reynolds JM, Liu Q, Brittingham KC, Liu Y, Gruenthal M, Gorgun CZ, et al. Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoim- mune encephalomyelitis. J Immunol 2007;179:313-321.
85. Rolph MS, Young TR, Shum BO, Gorgun CZ, Schmitz-Peiffer C, Ramshaw IA, et al. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol 2006;177:7794-7801.
86. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signal- ing and immunity. Nat Immunol 2003;4:1169-1176.
87. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signal- ling and immune regulation. Nat Rev Immunol 2007;7:454-465.
88. Chinen T, Kobayashi T, Ogata H, Takaesu G, Takaki H, Hashi- moto M, et al. Suppressor of cytokine signaling-1 regulates inflam- matory bowel disease in which both IFNgamma and IL-4 are involved. Gastroenterology 2006;130:373-388.
89. Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, Takaesu G, et al. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol 2008;180:3746-3756.
90. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinaka- mura H, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004;10:739-743.
91. Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and trans- forming growth factor-beta 1. J Exp Med 2006;203:1021-31.
92. Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, et al. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 2009;183:97-105.